← Back to Clinical Trials
Recruiting NCT03193151
Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation
Trial Parameters
Condition Liver Dysfunction
Sponsor University of Alberta
Study Type OBSERVATIONAL
Phase N/A
Enrollment 300
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2017-12-19
Completion 2026-12
Interventions
liver biopsy
Brief Summary
INTERLIVER is a prospective observational study of the relationship of the molecular phenotype of 300 liver transplant biopsies to the histologic phenotype and the clinical features and outcomes. A segment of a biopsy performed as standard-of-care for indications, or by center protocol, will be used for gene expression study.
Eligibility Criteria
Inclusion Criteria: * biopsy for clinical indications Exclusion Criteria: * no consent, pregnant women